Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials-Reference-Cited by-同舟云学术

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials

Published:2022-09 Issue:9 Volume:22 Page:1374-1387
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Leach Amanda Jane,Wilson Nicole,Arrowsmith Beth,Beissbarth Jemima,Mulholland Edward Kim,Santosham Mathuram,Torzillo Paul John,McIntyre Peter,Smith-Vaughan Heidi,Chatfield Mark D,Lehmann Deborah,Binks Michael,Chang Anne B,Carapetis Jonathan,Krause Vicki,Andrews Ross,Snelling Tom,Skull Sue A,Licciardi Paul V,Oguoma Victor M,Morris Peter Stanley

Funder

National Health and Medical Research Council

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference25 articles.

1. The impact of hearing impairment on early academic achievement in Aboriginal children living in remote Australia: a data linkage study;Su;BMC Public Health,2020

2. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules;Leach;BMC Pediatr,2014

3. Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in Indigenous and non-Indigenous Australians;Meder;Clin Infect Dis,2020

4. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H influenzae protein D conjugate vaccine;Leach;BMC Pediatr,2015

5. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines;Leach;Int J Pediatr Otorhinolaryngol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis;Health Technology Assessment;2024-07

2. Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules;PLOS Medicine;2024-06-03

3. Hearing loss at 6-monthly assessments from age 12 to 36 months: secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules;2024-03-15

4. ISOM 2023 Research Panel 5: Interventions- Vaccines and prevention, medical and surgical treatment, and impact of COVID-19 pandemic;International Journal of Pediatric Otorhinolaryngology;2024-01

5. Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines;International Journal of Pediatric Otorhinolaryngology;2023-12